
United Natural Foods, Inc. (UNFI) has reported its fiscal fourth quarter and full year 2024 financial results, showing significant growth in several key metrics. The company saw a 10% increase in net sales, reaching $8.2 billion, and a 53.8% rise in adjusted EBITDA to $143 million, which includes a $10 million benefit. Despite these gains, UNFI reported a net loss of $37 million, translating to a loss per diluted share of $0.63. The company's CEO stated that the Q4 results drove fiscal 2024 performance to the upper end of their previously provided outlook. Additionally, UNFI's stock has seen a positive response, with pre-market trading showing an 8.56% increase to $18.26. Separately, Kahn Swick & Foti, LLC has initiated an investigation into the officers and directors of United Natural Foods, Inc.
Upside: $SGMT +16% (receives FDA Breakthrough Therapy Designation for Denifanstat in MASH) $ARCO +11% (exercises renewal option for 20-year Master Franchise Agreement with McDonald’s, effective Jan 1st 2025) $IVDA +9.0% (launches IvedaESS, a portable, plug-and-play security…
📈 FSMN PRE-MARKET MOVERS 📉 Top Gainers • Arcos Dorados Holdings $ARCO Up 18.23% To $10.31 • United Natural Foods $UNFI Up 8.56% To $18.26 • Oruka Therapeutics $ORKA Up 8.03% To $26.48 • Stratasys $SSYS Up 7.46% To $8.93 • LexinFintech Holdings $LX Up 6.98% To $2.91 •…
$UNFI (+6.2% pre) United Natural Foods rallies after posting double-digit revenue growth - SA https://t.co/45XmhYseQa




